According to Gen Consulting Company, the global digital therapeutics market is set to achieve an incremental growth of USD 8 billion, acelerating at a CAGR of almost 18.7% during the forecast period 2022-2028.

This industry report offers market estimates of the global market, followed by a detailed analysis of the application, end user, and region. The global market data on digital therapeutics can be segmented by application: cardiovascular diseases (CVD), central nervous system (CNS) diseases, diabetes, obesity, respiratory diseases, smoking cessation, others. Digital therapeutics market is further segmented by end user: employers, patients, payers, providers, others. Based on region, the digital therapeutics market is segmented into: North America, Europe, Asia-Pacific, Rest of the World.

The global digital therapeutics market is highly competitive. Some of the leading companies operating in the market are 2Morrow Inc., Canary Health Inc., FITBIT Inc., NOOM INC., Omada Health Inc., Pear Therapeutics Inc., Propeller Health (ResMed Inc.), Teladoc Health Inc., TrialCard Incorporated, Twill Inc., Welldoc Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
– Get a detailed picture of the Global Digital Therapeutics Market
– Identify segments/areas to invest in over the forecast period in the Global Digital Therapeutics Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.